0HRLX72
Replacement Skin, Left Lower Leg to Cell Suspension Technique with Autologous Tissue Substitute, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | H Skin and Breast |
| Operation | R Replacement |
| Body Part | L Skin, Left Lower Leg |
| Approach | X External |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | 2 Cell Suspension Technique |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in the skin and breast involve putting in material, biological or synthetic, that physically takes over for tissue that has been removed or is absent. The clearest example is breast implant placement following mastectomy, where a saline or silicone implant substitutes for the breast tissue that was removed. Skin grafting for extensive wounds or burns, where donor or synthetic skin substitutes for tissue that cannot heal on its own, also falls into this family.
These procedures are performed when tissue loss is too extensive for simple repair, or when a body part such as the breast has been surgically removed and the patient elects reconstruction. The replacement material can come from the patient's own body, a donor, or be entirely synthetic, and it is meant to remain in place, unlike a temporary dressing or expander used only to stretch skin.
Timing varies considerably: some replacements happen in the same operation as the tissue removal, known as immediate reconstruction, while others are staged over months, especially when tissue expanders are used first to prepare the site before the permanent implant or flap is placed.
Anatomy & Axis Detail
Skin, Left Lower Leg
Skin replacement on the left lower leg addresses the same anatomic challenges as the right: a thin soft tissue envelope directly over the tibia and fibula with limited local flap options and a predisposition to venous stasis changes that impair healing. This site is a frequent target for grafting after chronic venous or arterial ulcers, post-traumatic wounds, or excision of skin cancers where surrounding tissue laxity is insufficient to close the defect primarily. Graft selection often weighs the leg's exposure to shear and pressure during ambulation, favoring meshed grafts anchored with sutures or staples and protected by compression dressings postoperatively. When bioengineered skin substitutes are used as a bridge before autografting, each application constitutes a separate replacement procedure, and the operative note should clarify staging so the correct sequence of codes is applied.
Approach: External
External approach applies to procedures performed directly on the skin or mucous membrane, or on an accessible body surface, without any instrumentation passing through a puncture or orifice. It covers things like manual reduction of a fracture or excision of a skin lesion. It differs from Via Natural or Artificial Opening in that no internal passage is entered at all, only the exposed surface.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Qualifier: Cell Suspension Technique
Cell Suspension Technique specifies that a procedure used a processed suspension of the patient's own skin cells, such as an autologous cell harvesting device, rather than a traditional sheet or mesh graft. It distinguishes this newer regenerative approach, often used for burn or wound coverage, from qualifiers describing conventional full thickness or partial thickness grafting.
Coding & Documentation
Coders need the operative report to specify the material used, since the qualifier distinguishes autologous tissue from synthetic or nonautologous substitutes, and this materially changes the code selected. Documentation must also make clear that the replaced body part or region is anatomically taking the place of what was removed, not simply reinforcing existing tissue.
A frequent mistake is coding Replacement when a tissue expander, a temporary device meant to be removed later, was placed rather than a permanent implant; expander insertion is typically coded as Insertion, not Replacement. Coders also sometimes miss that a two-stage breast reconstruction requires separate codes at each encounter, one for expander insertion and later for expander removal with implant replacement. Confusion also arises between an implant placed directly after mastectomy versus one placed as a delayed procedure much later, which does not change the root operation but affects timing and history documentation coders should note.